These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 36915720)
1. Prevalence of the Gaafar A; Al-Omar HM; Manogaran PS; Almohareb F; Alhussein K Am J Transl Res; 2023; 15(2):967-981. PubMed ID: 36915720 [TBL] [Abstract][Full Text] [Related]
2. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells. Sato K; Nagayama H; Takahashi TA Cryobiology; 1998 Dec; 37(4):362-71. PubMed ID: 9917353 [TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689 [TBL] [Abstract][Full Text] [Related]
4. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity. Zhao W; Xing P; Wei X; Wang T; Yang D; Li M Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098 [TBL] [Abstract][Full Text] [Related]
5. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha. Wang C; Al-Omar HM; Radvanyi L; Banerjee A; Bouman D; Squire J; Messner HA Exp Hematol; 1999 Jul; 27(7):1176-84. PubMed ID: 10390193 [TBL] [Abstract][Full Text] [Related]
6. Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib. Lemoli RM; Salvestrini V; Bianchi E; Bertolini F; Fogli M; Amabile M; Tafuri A; Salati S; Zini R; Testoni N; Rabascio C; Rossi L; Martin-Padura I; Castagnetti F; Marighetti P; Martinelli G; Baccarani M; Ferrari S; Manfredini R Blood; 2009 Dec; 114(25):5191-200. PubMed ID: 19855080 [TBL] [Abstract][Full Text] [Related]
9. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells. Dilioglou S; Cruse JM; Lewis RE Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622 [TBL] [Abstract][Full Text] [Related]
10. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal. Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172 [TBL] [Abstract][Full Text] [Related]
11. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes. Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800 [TBL] [Abstract][Full Text] [Related]
12. Generation of dendritic cells from patients with chronic myelogenous leukemia. Heinzinger M; Waller CF; von den Berg A; Rosenstiel A; Lange W Ann Hematol; 1999 Apr; 78(4):181-6. PubMed ID: 10348149 [TBL] [Abstract][Full Text] [Related]
13. Efficient ex vivo generation of human dendritic cells from mobilized CD34+ peripheral blood progenitors. Ohishi K; Katayama N; Mitani H; Araki H; Masuya M; Suzuki H; Hoshino N; Miyashita H; Nishii K; Kageyama S; Minami N; Shiku H Int J Hematol; 2001 Oct; 74(3):287-96. PubMed ID: 11721965 [TBL] [Abstract][Full Text] [Related]
14. Circulating myeloid dendritic cell directly isolated from patients with chronic myelogenous leukemia are functional and carry the bcr-abl translocation. Orsini E; Calabrese E; Maggio R; Pasquale A; Nanni M; Trasarti S; Tafuri A; Guarini A; Foa R Leuk Res; 2006 Jul; 30(7):785-94. PubMed ID: 16527350 [TBL] [Abstract][Full Text] [Related]
15. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients. Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957 [TBL] [Abstract][Full Text] [Related]
16. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Dilioglou S; Cruse JM; Lewis RE Exp Mol Pathol; 2003 Dec; 75(3):217-27. PubMed ID: 14611813 [TBL] [Abstract][Full Text] [Related]
17. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848 [TBL] [Abstract][Full Text] [Related]
18. Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia. Zheng C; Pisa P; Stromberg O; Blennow E; Hansson M Med Oncol; 2000 Nov; 17(4):270-8. PubMed ID: 11114705 [TBL] [Abstract][Full Text] [Related]
19. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients. Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602 [TBL] [Abstract][Full Text] [Related]
20. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Buckle AM; Mottram R; Pierce A; Lucas GS; Russell N; Miyan JA; Whetton AD Mol Med; 2000 Oct; 6(10):892-902. PubMed ID: 11126203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]